Pharmaceutical Sector

.

Seven Year Long Lawsuit against Cephalon Settled with Teva Pharmaceuticals Paying $1.2 Billion

Seven Year Long Lawsuit against Cephalon Settled with Teva Pharmaceuticals Payin

On Thursday, the U. S. Federal Trade Commission (F. T. C) announced that the seven year long lawsuit against Cephalon, which was bought by Teva in 2011, will be settled for $1.2 billion.

Mylan says Speculations of an Acquisition by Teva is a Rumour

Mylan says Speculations of an Acquisition by Teva is a Rumour

On Friday, Mylan, the Dutch generic drug making company said that speculation which says that that company may be acquired by Teva Pharmaceutical is just a rumour and it doubts whether the regulators would even approve this kind of a deal. The drug makes said that it decides to remain a stand-alone company.

Orexigen Therapeutics Inc’s Anti-Obesity Drug Contrave, May Benefit Cardiovascular Patients

Orexigen Therapeutics Inc’s Anti-Obesity Drug Contrave, May Benefit Cardiovascul

Orexigen Therapeutics Inc's report which said that Contrave, its anti-obesity drug offers surprising benefits to cardiovascular patients helped the company to gain greater than thirty percent on Tuesday.

However the disclosure by the company based in Miami, made the Food and Drug Administration to ask for a second run on the cardiovascular outcomes trial.

Valeant Pharmaceuticals International Inc. to Acquire Salix Pharmaceuticals Ltd in a Cash Deal of Approximately $10.1 Billion

Valeant Pharmaceuticals International Inc. to Acquire Salix Pharmaceuticals Ltd

Valeant Pharmaceuticals International Inc. will be acquiring Salix Pharmaceuticals Ltd. in a cash deal worth approximately $10.1 billion. This move will allow Valeant to add a range of gastrointestinal drugs to its line of offerings.

To Escape Persistent Moves from Valeant Allergan Set to Sell Itself to Actavis

To Escape Persistent Moves from Valeant Allergan Set to Sell Itself to Actavis

To escape an unwanted takeover from Valeant Pharmaceuticals International, the Botox maker Allergan, in its recent defensive move, is planning to sell itself to another bidder Actavis.

New Tax Rules Can Discourage $55 billion AbbVie And Shire Pharma Merger

New Tax Rules Can Discourage $55 billion AbbVie And Shire Pharma Merger

The$55 billion merger deal of Chicago-based AbbVie with Shire, its U. K. rival could be the first victim of the new rules set by the Obama Administration to clean-up inversion deals.

Pharmaceutical Industry Jostle for Takeover Deals

Pharmaceutical Industry Jostle for Takeover Deals

The pharmaceutical industry is going through a lot of buzz as a number of companies are engaged in talks for acquisition and making deals. Some of the bigger players are busy trying to out-power their competitors.

Wockhardt Ltd soars after receiving QIDP status for two drugs

Wockhardt Ltd soars after receiving QIDP status for two drugs

Wockhardt Ltd BSE 3.72 % went up to 6.2 per cent in exchange on Monday, after the pharma major said that its new medication revelation program in hostile to infective exploration and has gotten a real help after two of its medications, WCK 771 and WCK 2349, got the Qualified Infectious Disease Product (QIDP) status from the US FDA.

Ackman and Valeant call for special meeting of Allergan shareholders

Ackman and Valeant call for special meeting of Allergan shareholders

William Ackman, who is an activist investor and Valeant Pharmaceuticals International have called for a special meeting with the shareholders of Allergan Inc over their takeover bid for the company.

Walgreen Looking Forward to Acquire 55% of Alliance Boots

Walgreen Looking Forward to Acquire 55% of Alliance Boots

Walgreen the major drugstore chain of late faced pressure from the shareholders to shift overseas so as to lessen its tax bill like many other drug companies have done recently. Walgreen was earlier looking forward to become a part of a possible agreement with Alliance Boots GmbH the European drugstore chain.

Latest News

Microsoft’s Monday Announcements; Agreement with AOL to Move Display Ads, Sells
Phil Knight, Nike’s Co-Founder will Leave the Chairman’s Post Next Year
In spite of Introducing Several Stimulus, China’s Economy Indicates Weakness
Puerto Rico’s Financial Problems Grow Further as Report Says It Can no Longer Me
The Reckless Murderer, Detroit Women Killed Two of Her Own Children!
FTC’s Lawsuit Drives Sysco to Annul Buyout Deal with US Foods
Increasing Shark Attacks in North Carolina Beaches; Is Shark Fishing to be Blame
Solar Impulse Starts its Flight Across the Pacific Ocean
California Regulators Ordered San Francisco to Stop Diverting River During Droug
Supreme Court’s Ruling Says Same-Sex Marriage is Unconstitutional to be Banned b
MTA Sued by Comedy Duo for Rejecting to Put-up anti-Islamophobia Posters on Subw
Syndicate content